JPMorgan downgraded TIC Solutions to Underweight from Neutral with a price target of $7, down from $8. The firm cites comparatively lower near-term upside for shares versus peers, rather than a negative long-term outlook, for the downgrade. JPMorgan has concerns around TIC's execution, margin pressure and integration of NV5.